Tianjin Tianyao Pharmaceuticals Co., Ltd. logo

Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)

Market Closed
11 Aug, 06:57
SSE SSE
¥
5. 93
-0.27
-4.3548%
¥
4.64B Market Cap
- P/E Ratio
0.35% Div Yield
123.28M Volume
- Eps
¥ 6.2
Previous Close
Add Transaction
Day Range
5.91 6.11
Year Range
3.68 8.44
Want to track 600488 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600488 closed today lower at ¥5.93, a decrease of -4.3548% from yesterday's close, completing a monthly increase of 22.7743% or ¥1.1. Over the past 12 months, 600488 stock gained 44.9878%.
600488 pays dividends to its shareholders, with the most recent payment made on Jul 14, 2026. The next estimated payment will be in In 11 months on Jul 14, 2027 for a total of ¥0.052.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0037%, based on the last three reports.
Tianjin Tianyao Pharmaceuticals Co., Ltd. has completed 5 stock splits, with the recent split occurring on Mar 13, 2013.
The company's stock is traded on one exchange.

600488 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488) FAQ

What is the stock price today?

The current price is ¥5.93.

On which exchange is it traded?

Tianjin Tianyao Pharmaceuticals Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600488.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.35%.

What is its market cap?

As of today, the market cap is 4.64B.

Has Tianjin Tianyao Pharmaceuticals Co., Ltd. ever had a stock split?

Tianjin Tianyao Pharmaceuticals Co., Ltd. had 5 splits and the recent split was on Mar 13, 2013.

Tianjin Tianyao Pharmaceuticals Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Shuxiang Li CEO
SSE Exchange
CNE000001840 ISIN
CN Country
2,678 Employees
14 Jul 2026 Last Dividend
26 May 2006 Last Split
24 May 2001 IPO Date

Overview

Tianjin Tianyao Pharmaceuticals Co., Ltd., established in 1999 and headquartered in Tianjin, China, focuses on the research, development, production, and sales of pharmaceutical products, particularly corticosteroids, amino acid active pharmaceutical ingredients (APIs), and a variety of medical preparations. The firm has marked its presence not only in China but also across multiple international markets, including the United States, Southeast Asia, Europe, South America, and Africa. Operating under the larger umbrella of Tianjin Pharmaceutical Group Co., Ltd., Tianjin Tianyao Pharmaceuticals has built a reputation for specializing in a critical segment of the pharmaceutical industry.

Products and Services

  • Corticosteroid Raw Materials - The company specializes in the production of various corticosteroid raw materials, which are integral to numerous medicinal products. Key substances include dexamethasone, prednisone, methylprednisolone, and betamethasone, catering to a wide range of therapeutic needs.
  • Amino Acid Raw Materials - Tianjin Tianyao Pharmaceuticals extends its expertise to amino acid raw materials, which are foundational components for many pharmaceutical applications, underscoring the company’s diverse capabilities in pharmaceutical ingredient production.
  • Dosage Forms - The company’s portfolio broadens to include an array of dosage forms to accommodate different patient needs and preferences. These forms comprise:
    • Injections - Liquid medicines administered directly into the body’s tissues.
    • Ointments, Creams - Topical applications for external use, aimed at treating a variety of conditions.
    • Hard Capsules, Pills - Oral dosage forms designed for ease of ingestion.
    • Freeze-dried Powder Injections - Lyophilized products that are reconstituted at the time of use, ensuring stability and potency.
    • Inhalation Preparations - Medications administered through the respiratory route, suitable for treating pulmonary conditions.
    • Tablets - A common and widely used oral dosage form, manufactured for a variety of therapeutic applications.

Contact Information

Address: No. 19, Xinye Ninth Street, Tianjin, China, 300462
Phone: 86 22 2416 0838